logo-horizontal-main.png
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
09. Dezember 2024 16:05 ET | OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
logo-horizontal-main.png
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04. Dezember 2024 16:15 ET | OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
logo-horizontal-main.png
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
12. November 2024 16:05 ET | OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
logo-horizontal-main.png
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06. November 2024 16:45 ET | OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
logo-horizontal-main.png
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16. Oktober 2024 16:15 ET | OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
logo-horizontal-main.png
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
12. August 2024 16:10 ET | OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Beta Costumer Revenue Path
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08. August 2024 16:05 ET | OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
logo-horizontal-main.png
Oncocyte Announces August Investor Conferences Participation
05. August 2024 16:05 ET | OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
logo-horizontal-main.png
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01. August 2024 16:05 ET | OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
MedTechGurus-Logo.jpg
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
11. Juli 2024 08:00 ET | Med Tech Gurus
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode